PE

Paul Ehlinger

Founder of Flamel.ai

Covington, Kentucky

Overview 

Paul Ehlinger is the Founder and CEO of Flamel.ai, a company that specializes in helping multi-location brands manage social media using AI. With a background in venture capital and experience as a Co-founder and Venture Partner at Sixty8 Capital, Paul has invested in companies like SupplyHive and Thrivable, focusing on sectors such as MarketingTech and AI. Paul's career highlights include founding Flamel.ai to revolutionize social media management for multi-location brands using AI technology, and his role as a Co-founder and Venture Partner at Sixty8 Capital, where he invested in innovative companies like Podchaser and FlyWire.

Work Experience 

  • Founder and CEO

    2022 - Current

    Flamel.ai enables multi-location franchises to turn each unit into a marketing engine. Drive meaningful engagement and conversion with local, personalized content while preserving brand integrity. Check us out at: www.flamel.ai

Flamel AI provides a fully AI-driven design studio for influencer marketing content.

Raised $2,000,000.00 from Fireroad Ventures, Allos Ventures, Dundee Venture Capital, Omaha Capital, Elevate Ventures and Flywheel Fund.

  • Co-founder and Venture Partner

    2020 - 2023

    Seen. Heard. Funded. We are the first Indiana-based Venture Capital firm dedicated to investing in Black, Brown, Women, LGBTQ+, and disabled founders. We use capital, connections, and community to support scalable and investable tech and tech-enabled companies.

Sixty8 Capital is a seed-stage venture capital firm focused on investing in diverse communities.

  • Director of Operations

    2021 - 2022

    Gifthealth streamlines your Rx experience with proprietary technology and a national network of pharmacy partners.

  • Investor/Board Member

    2021 - 2021

GiftHealth is a healthcare tech startup that streamlines pharmacy experience with free delivery and competitive medication pricing.

Raised $45,800,000.00 from Eir Partners.

  • Principal

    2019 - 2021

    Partnering with and building high-growth tech companies in the heart of the Midwest.

Allos Ventures invests in early-stage B2B software and business services companies in the Midwest.

  • Investment Manager, Kentucky Enterprise Fund

    2018 - 2019

    The Kentucky Enterprise Fund (KEF) is the most active venture investor in the state of Kentucky. It is a pre-seed and seed-stage fund with an active portfolio of 60 companies (120+ in total) and >$30MM in assets under management.

  • Associate, KEF

    2017 - 2018

The Kentucky Science and Engineering Foundation (KSEF) invests in research and development .

  • R&D Engineer

    2016 - 2017

    I joined Wallaby Medical as the 7th employee and as a part of the core engineering team. While here, I helped develop a patented neurovascular coil system for the treatment of brain aneurysms in an international startup environment. Recently, the device received the CE Mark approval and FDA 510(k) clearance. My roles included, but weren’t limited to: managing the design of implant delivery system based on key opinion leader feedback, creating and implementing quality, test, and manufacturing protocols in accordance to ISO 13485 and good manufacturing procedures, and training and managing a team of six technicians in protocol and device development.

Wallaby Medical is a manufacturing company that produces avenir coil system and medical devices for stroke treatment.

  • R&D Engineer

    2015 - 2016

    I began my career as an intern with Medtronic on their neurovascular R&D team. During my internship, I developed a modeling tool to reduce the need for benchtop testing of early design iterations by predicting principal strains and stresses of 3D solid models. This project led to a full time position with the R&D team where I worked with senior team members on the design of a flow-diverting neurovascular stent for the treatment of wide-neck aneurysms. My responsibilities included: development of test and manufacturing protocols, transfer of product to the main manufacturing floor, and design verification testing.

  • R&D Engineer Intern (Neurovascular)

    2015 - 2015

Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.

Raised $9,105,978,217.00 from NHS England.

  • Research Assistant

    2012 - 2014

    o Designed an ex-vivo cell culture system to investigate the effects of differentiated pressure on cardiomyocyte cells o Cultured HL-1 mouse cardiomyocyte and MCF-7 human breast cancer cells o Performed mRNA isolation, cDNA synthesis, Real-Time PCR, and radioactive ligand binding experiments on multiple mammalian cell lines to investigate adipocytokine expression o Trained new laboratory members in several key experimental methods and lab protocols

  • Research Assistant

    2011 - 2012

    o Developed and implemented a series of false positive tests for quality assurance testing of a device for the photoacoustic detection of circulating melanoma cells o Used AutoCAD software to design and then fabricate a two phase flow chamber to alleviate ambient noise in the device o Assisted a fellow undergraduate researcher in adapting the melanoma detection device to instead detect circulating E. coli bacteria o Worked cooperatively under a PhD student to build an oscillating motor for an optical surgery fiber optic despeckler

Articles About Paul

Relevant Websites